Literature DB >> 27514291

Supportive and symptomatic management of amyotrophic lateral sclerosis.

Esther V Hobson1, Christopher J McDermott1.   

Abstract

The main aims in the care of individuals with amyotrophic lateral sclerosis (ALS) are to minimize morbidity and maximize quality of life. Although no cure exists for ALS, supportive and symptomatic care provided by a specialist multidisciplinary team can improve survival. The basis for supportive management is shifting from expert consensus guidelines towards an evidence-based approach, which encourages the use of effective treatments and could reduce the risk of harm caused by ineffective or unsafe interventions. For example, respiratory support using noninvasive ventilation has been demonstrated to improve survival and quality of life, whereas evidence supporting other respiratory interventions is insufficient. Increasing evidence implicates a causal role for metabolic dysfunction in ALS, suggesting that optimizing nutrition could improve quality of life and survival. The high incidence of cognitive dysfunction and its impact on prognosis is increasingly recognized, although evidence for effective treatments is lacking. A variety of strategies are used to manage the other physical and psychological symptoms, the majority of which have yet to be thoroughly evaluated. The need for specialist palliative care throughout the disease is increasingly recognized. This Review describes the current approaches to symptomatic and supportive care in ALS and outlines the current guidance and evidence for these strategies.

Entities:  

Mesh:

Year:  2016        PMID: 27514291     DOI: 10.1038/nrneurol.2016.111

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  111 in total

1.  Shared decision making: really putting patients at the centre of healthcare.

Authors:  A M Stiggelbout; T Van der Weijden; M P T De Wit; D Frosch; F Légaré; V M Montori; L Trevena; G Elwyn
Journal:  BMJ       Date:  2012-01-27

2.  Non-invasive ventilation in amyotrophic lateral sclerosis: a 10 year population based study.

Authors:  Adriano Chiò; Andrea Calvo; Cristina Moglia; Federica Gamna; Alessio Mattei; Letizia Mazzini; Gabriele Mora
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-10-19       Impact factor: 10.154

3.  Use of intrathecal baclofen for treatment of spasticity in amyotrophic lateral sclerosis.

Authors:  G Marquardt; V Seifert
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

4.  Nocturnal pulse oximetry: a new approach to establish the appropriate time for non-invasive ventilation in ALS patients.

Authors:  Anabela Pinto; Mamede de Carvalho; Teresinha Evangelista; Arminda Lopes; Lurdes Sales-Luís
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2003-04

5.  A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

Authors:  Alan E Renton; Elisa Majounie; Adrian Waite; Javier Simón-Sánchez; Sara Rollinson; J Raphael Gibbs; Jennifer C Schymick; Hannu Laaksovirta; John C van Swieten; Liisa Myllykangas; Hannu Kalimo; Anders Paetau; Yevgeniya Abramzon; Anne M Remes; Alice Kaganovich; Sonja W Scholz; Jamie Duckworth; Jinhui Ding; Daniel W Harmer; Dena G Hernandez; Janel O Johnson; Kin Mok; Mina Ryten; Danyah Trabzuni; Rita J Guerreiro; Richard W Orrell; James Neal; Alex Murray; Justin Pearson; Iris E Jansen; David Sondervan; Harro Seelaar; Derek Blake; Kate Young; Nicola Halliwell; Janis Bennion Callister; Greg Toulson; Anna Richardson; Alex Gerhard; Julie Snowden; David Mann; David Neary; Michael A Nalls; Terhi Peuralinna; Lilja Jansson; Veli-Matti Isoviita; Anna-Lotta Kaivorinne; Maarit Hölttä-Vuori; Elina Ikonen; Raimo Sulkava; Michael Benatar; Joanne Wuu; Adriano Chiò; Gabriella Restagno; Giuseppe Borghero; Mario Sabatelli; David Heckerman; Ekaterina Rogaeva; Lorne Zinman; Jeffrey D Rothstein; Michael Sendtner; Carsten Drepper; Evan E Eichler; Can Alkan; Ziedulla Abdullaev; Svetlana D Pack; Amalia Dutra; Evgenia Pak; John Hardy; Andrew Singleton; Nigel M Williams; Peter Heutink; Stuart Pickering-Brown; Huw R Morris; Pentti J Tienari; Bryan J Traynor
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

6.  Management of sialorrhoea in motor neuron disease: a survey of current UK practice.

Authors:  Esther V Hobson; Alexander McGeachan; Ammar Al-Chalabi; Siddharthan Chandran; Francesca Crawley; David Dick; Colette Donaghy; John Ealing; Cathy M Ellis; George Gorrie; C Oliver Hanemann; Timothy Harrower; Agam Jung; Tahir Majeed; Andrea Malaspina; Karen Morrison; Richard W Orrell; Hardev Pall; Ashwin Pinto; Kevin Talbot; Martin R Turner; Timothy L Williams; Carolyn A Young; Pamela J Shaw; Christopher J McDermott
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-05-07       Impact factor: 4.092

7.  Developing and evaluating complex interventions: the new Medical Research Council guidance.

Authors:  Peter Craig; Paul Dieppe; Sally Macintyre; Susan Michie; Irwin Nazareth; Mark Petticrew
Journal:  BMJ       Date:  2008-09-29

8.  Eating-derived pleasure in amyotrophic lateral sclerosis as a predictor of non-oral feeding.

Authors:  Julia Johnson; P Nigel Leigh; Christopher E Shaw; Cathy Ellis; Rachel Burman; Ammar Al-Chalabi
Journal:  Amyotroph Lateral Scler       Date:  2012-08-07

9.  Screening for cognition and behaviour changes in ALS.

Authors:  Sharon Abrahams; Judith Newton; Elaine Niven; Jennifer Foley; Thomas H Bak
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-06-19       Impact factor: 4.092

10.  The initiation of non-invasive ventilation for patients with motor neuron disease: patient and carer perceptions of obstacles and outcomes.

Authors:  Susan K Baxter; Wendy O Baird; Sue Thompson; Stephen M Bianchi; Stephen J Walters; Ellen Lee; Sam H Ahmedzai; Alison Proctor; Pamela J Shaw; Christopher J McDermott
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2012-09-06       Impact factor: 4.092

View more
  38 in total

Review 1.  Advances in the discovery of genetic risk factors for complex forms of neurodegenerative disorders: contemporary approaches, success, challenges and prospects.

Authors:  Sumeet Kumar; Navneesh Yadav; Sanjay Pandey; B K Thelma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

2.  Amyotrophic Lateral Sclerosis: An Acupuncture Approach.

Authors:  Poovadan Sudhakaran
Journal:  Med Acupunct       Date:  2017-10-01

3.  Symptom management in amyotrophic lateral sclerosis: We can do better.

Authors:  Stephen A Goutman; Zachary Simmons
Journal:  Muscle Nerve       Date:  2017-08-30       Impact factor: 3.217

4.  Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System.

Authors:  Anna Gaimari; Michele Fusaroli; Emanuel Raschi; Elisa Baldin; Luca Vignatelli; Francesco Nonino; Fabrizio De Ponti; Jessica Mandrioli; Elisabetta Poluzzi
Journal:  Drug Saf       Date:  2022-05-24       Impact factor: 5.606

Review 5.  Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD.

Authors:  Hongbo Chen; Mark W Kankel; Susan C Su; Steve W S Han; Dimitry Ofengeim
Journal:  Cell Death Differ       Date:  2018-02-19       Impact factor: 15.828

Review 6.  SIRT1 Promotes Neuronal Fortification in Neurodegenerative Diseases through Attenuation of Pathological Hallmarks and Enhancement of Cellular Lifespan.

Authors:  Priya Mishra; Amit Kumar Mittal; Harikesh Kalonia; Swati Madan; Shampa Ghosh; Jitendra Kumar Sinha; Satyendra Kumar Rajput
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

Review 7.  Diagnostics of Amyotrophic Lateral Sclerosis: Up to Date.

Authors:  Ivana Štětkářová; Edvard Ehler
Journal:  Diagnostics (Basel)       Date:  2021-02-03

8.  Amyotrophic Lateral Sclerosis: Integrated care provides the best quality of life.

Authors:  Jonathan R Brent; Senda Ajroud-Driss
Journal:  Pract Neurol (Fort Wash Pa)       Date:  2019 Jul-Aug

Review 9.  [Poly adenosine diphosphate-ribosylation and neurodegenerative diseases].

Authors:  Yi Wang; Yunbi Lu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

Review 10.  Applications of focused ultrasound in the brain: from thermoablation to drug delivery.

Authors:  Ying Meng; Kullervo Hynynen; Nir Lipsman
Journal:  Nat Rev Neurol       Date:  2020-10-26       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.